Cannabidiol significantly reduces seizures in Lennox-Gastaut syndrome

cannabidiol-vial

In a new study published in The New England Journal of Medicine the researchers, comparing two doses of Cannabidiol (CBD) to a placebo, reported a 41.9 percent reduction in "drop seizures" in patients taking a 20 mg/kg/d Cannabidiol (CBD) regimen, a 37.2 percent reduction in those on a 10 mg/kg/d Cannabidiol (CBD) regimen, and a 17.2 percent reduction in a group given a placebo. The phase III trial was led by principal investigator and study first co-author Orrin Devinsky, MD, a professor of neurology, neurosurgery, and psychiatry at NYU School of Medicine and director of NYU Langone's Comprehensive Epilepsy Center. The study...
Continue reading
  967 Hits
967 Hits
Select Language

ICNApedia Community Pages

Journal of the International Child Neurology Association

icnapedia vle

ICNC2018 Mumbai India